Takeda Starts to Map Out Shire Plan as Financing on Track (1)

Takeda Pharmaceutical Co. said the company is shaping its strategy to absorb Shire Plc, with regulatory approvals and financing preparations on track for the $62 billion acquisition.

“We are starting to map what integration would look like and also strategically how we can get organized in the future,” said Chief Executive Officer Christophe Weber during a conference call announcing the drugmaker’s first earnings since the Shire agreement was reached. “The integration team is working in 20 different areas from both Takeda and Shire.”

The Japanese company has been selling off its non-core holdings, and Weber said on the call that ...